Finally, paclitaxel resistance could also be observed in an additional breast cancer cell line (MDA-MB-453) stably transfected with ZNF217 when compared to control cells (data not shown), suggesting that the paclitaxel-resistant phenotype developed by ZNF217-overexpressing cells occurs in different breast cancer cell lines. The gene discussed is ZNF217; the disease is breast carcinoma.